--- title: "Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference | CRVS Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/287111117.md" description: "Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference | CRVS Stock News" datetime: "2026-05-20T12:01:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287111117.md) - [en](https://longbridge.com/en/news/287111117.md) - [zh-HK](https://longbridge.com/zh-HK/news/287111117.md) generator: "portal-rs" --- # Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference | CRVS Stock News Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference | CRVS Stock News ### Related Stocks - [CRVS.US](https://longbridge.com/en/quote/CRVS.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) ## Related News & Research - [Wellington Management Group LLP Has $40.81 Million Stock Position in Corvus Pharmaceuticals, Inc. $CRVS](https://longbridge.com/en/news/298104940.md) - [Corvus Pharmaceuticals (CRVS) to Post Quarterly Earnings on Thursday](https://longbridge.com/en/news/294346824.md) - [Corvus Pharmaceuticals (NASDAQ:CRVS) Posts Earnings Results, Misses Expectations By $0.03 EPS](https://longbridge.com/en/news/295291601.md) - [Renaissance Technologies LLC Takes $1.19 Million Position in Corvus Pharmaceuticals, Inc. $CRVS](https://longbridge.com/en/news/295904031.md) - [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**